SUBCHONDRAL SOLUTIONS NOW APPROVED AS VENDOR FOR TENET HEALTHCARE

COSTA MESA, CALIF. -- Subchondral Solutions, Inc., an orthopedic medical device company based in Huntington Beach, Calif., has achieved approved vendor status for its S-Core® platform technology™ from Tenet Healthcare. Tenet Healthcare operates 61 acute care and specialty hospitals, more than 110 outpatient facilities, and has ownership interests in more than 465 ambulatory surgery centers and hospitals.

Subchondral’s S-Core® product is an innovative delivery platform for subchondral bone damage in most joints to help restore biomechanical function. S-Core® Implants are coated with hydroxyapatite to maximize bone and biologic healing.

“The vendor contract with Tenet is an additional example of the growing acceptance of S-Core® as an orthopedic implant device that helps delay the onset of end stage osteoarthritis,” says Tom Kinder, CEO of Subchondral Solutions. “The technology enables patients to stay active and pain free.” 

  Cleared by the FDA in 2020, the S-Core® delivery platform is indicated for the fixation of small bone fragments, such as osteochondral fragments and cancellous fragments, appropriate for the size of the damage area which may include the following: simple metaphyseal fractures; condylar fractures; osteochondritis dissecans; areas where accurate implant placement is vital; patellar fractures, navicular fractures, cancellous bone fragments; osteochondral fragments, intra-articular fractures and osteochondral fixation and fractures, and minimally invasive reconstruction of fractures and joints. S-Core® can be used in any osteochondral fracture appropriate for the size of the device, including for the knee, elbow, hand, foot, ankle and shoulder.

Subchondral’s S-Core® delivery platform technology is approved for use at Tenet facilities nationwide, and physicians at Tenet Healthcare have authorization to utilize Subchondral Solutions surgical products. 

###

About Subchondral Solutions, Inc.

Subchondral Solutions was formed in 2015 and is committed to advancing the treatment of joint damage by addressing the source of the problem with a biomechanical, efficient, cost-effective scalable system. Contact us at 888-410-5622 or online at subchondralsolutions.com.